蛋白酶体抑制剂治疗浆细胞疾病的研究进展(7)
[34] Castillo JJ， Kastritis E， Treon SP. Waldenstr？m macroglobulinemia： lessons learned from basic and clinical research[J]. Hematol Oncol Clin North Am， 2018， 32(5)： xiii-xiv.
[35] Treon SP， Ioakimidis L， Soumerai JD， et al. Primary therapy of Waldenstr？m macroglobulinemia with bortezomib， dexamethasone， and rituximab： WMCTG clinical trial 05-180[J]. J Clin Oncol， 2009， 27(23)： 3830-3835.
[36] Ghobrial IM， Xie W， Padmanabhan S， et al. Phase II trial of weekly bortezomib in combination with rituximab in untreated patients with Waldenstr？m macroglobulinemia [J]. Am J Hematol， 2010， 85(9)： 670-674.
[37] Dimopoulos MA， García-Sanz R， Gavriatopoulou M， et al. Primary therapy of Waldenstrom macroglobulinemia (WM) with weekly bortezomib， low-dose dexamethasone， and rituximab (BDR)： long-term results of a phase 2 study of the European Myeloma Network (EMN) [J]. Blood， 2013， 122(19)： 3276-3282.
[38] Treon SP， Tripsas CK， Meid K， et al. Carfilzomib， rituximab， and dexamethasone (CaRD) treatment offers a neuropathy-sparing approach for treating Waldenstr？m’s macroglobulinemia [J]. Blood， 2014， 124(4)： 503-510., http://www.100md.com(戴昕 陈彤)
[35] Treon SP， Ioakimidis L， Soumerai JD， et al. Primary therapy of Waldenstr？m macroglobulinemia with bortezomib， dexamethasone， and rituximab： WMCTG clinical trial 05-180[J]. J Clin Oncol， 2009， 27(23)： 3830-3835.
[36] Ghobrial IM， Xie W， Padmanabhan S， et al. Phase II trial of weekly bortezomib in combination with rituximab in untreated patients with Waldenstr？m macroglobulinemia [J]. Am J Hematol， 2010， 85(9)： 670-674.
[37] Dimopoulos MA， García-Sanz R， Gavriatopoulou M， et al. Primary therapy of Waldenstrom macroglobulinemia (WM) with weekly bortezomib， low-dose dexamethasone， and rituximab (BDR)： long-term results of a phase 2 study of the European Myeloma Network (EMN) [J]. Blood， 2013， 122(19)： 3276-3282.
[38] Treon SP， Tripsas CK， Meid K， et al. Carfilzomib， rituximab， and dexamethasone (CaRD) treatment offers a neuropathy-sparing approach for treating Waldenstr？m’s macroglobulinemia [J]. Blood， 2014， 124(4)： 503-510., http://www.100md.com(戴昕 陈彤)